In support, downregulation of SigmaR1 or the application of an inhibitory SigmaR1 ligand igmesine in breast and colon cancer cells has abolished the interplay of SK3 with Orai1 channels in lipid rafts and decreased their levels in lipid nanodomains [271]. This evidence concerns the gene KCNN3 and colonic neoplasm.